EFFICACY AND SAFETY OF ZOFENOPRIL + HYDROCHLOROTHIAZIDE COMBINATION VS. IRBESARTAN + HYDROCHLOROTHIAZIDE COMBINATION IN ESSENTIAL HYPERTENSIVE PATIENTS NOT CONTROLLED BY PREVIOUS MONOTHERAPY.

Trial Profile

EFFICACY AND SAFETY OF ZOFENOPRIL + HYDROCHLOROTHIAZIDE COMBINATION VS. IRBESARTAN + HYDROCHLOROTHIAZIDE COMBINATION IN ESSENTIAL HYPERTENSIVE PATIENTS NOT CONTROLLED BY PREVIOUS MONOTHERAPY.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jun 2013

At a glance

  • Drugs Zofenopril (Primary) ; Hydrochlorothiazide; Irbesartan
  • Indications Essential hypertension
  • Focus Registrational; Therapeutic Use
  • Acronyms ZENITH
  • Most Recent Events

    • 14 Jun 2013 Results presented at the 23rd European Meeting on Hypertension.
    • 03 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 02 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top